NO-13065
/ Otsuka
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
November 02, 2023
Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Food Effect of NO-13065 in Healthy and Obese Adult Subjects
(clinicaltrials.gov)
- P1 | N=84 | Completed | Sponsor: Otsuka Pharmaceutical Factory, Inc. | Active, not recruiting ➔ Completed
Trial completion • Genetic Disorders • Obesity
April 20, 2022
Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Food Effect of NO-13065 in Healthy and Obese Adult Subjects
(clinicaltrials.gov)
- P1 | N=84 | Active, not recruiting | Sponsor: Otsuka Pharmaceutical Factory, Inc. | Recruiting ➔ Active, not recruiting | Trial completion date: May 2022 ➔ Sep 2022
Enrollment closed • Trial completion date • Genetic Disorders • Obesity
1 to 2
Of
2
Go to page
1